Loading company…
Riskpilot
← Back to search
Sign in
Get full access
viva text & pharma AB
AB
Active
Org 5568299837
Munkhagsgatan 25
Literary creation and musical composition activities · NACE 9011
Est. 2010
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 615K
0% vs 2024
EBITDA margin
-1.7%
+97% vs 2024
Equity ratio
84.8%
Financial strength
Net profit 2025
SEK -16K
+94% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 615K
+0%
EBITDA
SEK -10K
+97%
Net profit
SEK -16K
+94%
Total assets
SEK 323K
-14%
Equity
SEK 274K
-6%
Employees
1
—
Company information
Legal name
viva text & pharma AB
Org number
5568299837
Legal form
Aktiebolag
NACE code
9011 · Literary creation and musical composition activities
Founded
7 december 2010
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget bedriver konsultverksamhet inom journalistik, media och läkemedelsområdet, samt därmed förenlig verksamhet.
Contact
Address
Munkhagsgatan 25
Phone
+46732512326
Email
fredrik@vivatextpharma.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Literary creation and musical composition activities
Companies in Strängnäs
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
1M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
655
588
900
618
615
Staff expenses
—
−646
−704
−690
−503
EBITDA
−94
−185
18
−294
−10
Depreciation & amort.
−0
—
—
—
—
EBIT
−94
−185
18
−294
−10
Net financials
65
254
7
30
−6
Profit before tax
−28
69
25
−265
−16
Tax
−0
−12
−7
—
—
Net profit
−28
57
18
−265
−16
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
865
654
681
375
323
Equity
667
537
555
290
274
Long-term debt
0
—
—
—
—
Short-term debt
198
117
126
85
49
Total debt
198
117
126
85
49
Financial ratios
5-year trend
EBITDA margin
-1.7%
This company
15.8%
Market median
-111% vs market
2021
2025
Equity ratio
84.8%
This company
38.2%
Market median
+122% vs market
2021
2025
Return on equity
-6.0%
This company
18.4%
Market median
-133% vs market
2021
2025
Net profit margin
-2.7%
This company
8.1%
Market median
-133% vs market
2021
2025
Asset turnover
1.91×
This company
1.12×
Market median
+71% vs market
2021
2025
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
MP
Martin Petter Hed
Deputy Board Member
2022
NF
Nils Fredrik Hed
Board of Directors
2020
Former (1)
AG
Anders Göran Hed
Deputy Board Member
2020 – 2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of viva text & pharma AB also hold positions in
0
other companies.
Person
Role here
Other companies
Anders Göran Hed
Deputy Board Member
0 companies
Martin Petter Hed
Deputy Board Member
0 companies
Nils Fredrik Hed
Board of Directors
0 companies